Back to search
Interleukin-2 or autologous lymphokine-activated killer cell treatment of malignant glioma: phase I trial.
Data up to Jan 2025
Published1986
Citations132
References0
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
Loading...